img

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities and Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 450 | Industry : Medical Care

Publisher : GRD Survery | Format : PDF

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Autologous Matrix-Induced Chondrogenesis (AMIC) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Autologous Matrix-Induced Chondrogenesis (AMIC) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Autologous Matrix-Induced Chondrogenesis (AMIC) market is estimated at $ 110 million in 2021, and projected to grow at a CAGR of 5.7% to $ 160 million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Autologous Matrix-Induced Chondrogenesis (AMIC) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Autologous Matrix-Induced Chondrogenesis (AMIC) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Polylactic-Co-Glycolic Acid (PGLA)
Others

Segmented by Application
Knee Cartilage Repair
Hip Cartilage Repair
Elbow Cartilage Repair
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Zimmer Biomet Holdings
Smith & Nephew plc
Matricel GmbH
JRI Orthopaedics Ltd.
Geistlich Pharma AG
CartiHeal
BioTissue AG
B. Braun Melsungen AG
Arthro-Kinetics
Anika Therapeutics, Inc.


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status and Forecast (2016-2027)
1.3.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Supply by Company
2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value by Company
2.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status by Type
3.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Type Introduction
3.1.1 Hyaluronic Acid
3.1.2 Collagen
3.1.3 Polyethylene Glycol (PEG)
3.1.4 Polylactic-Co-Glycolic Acid (PGLA)
3.1.5 Others
3.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status by Application
4.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Segment by Application
4.1.1 Knee Cartilage Repair
4.1.2 Hip Cartilage Repair
4.1.3 Elbow Cartilage Repair
4.1.4 Others
4.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status by Region
5.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Region
5.2 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
5.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
5.4 Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
5.5 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
5.6 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
6 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
6.1 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
7.1 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
8.1 Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
9.1 Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Status
10.1 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Type and by Application
12.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Forecast (2022-2027)
12.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecast by Type
12.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecast by Application
13 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Region/Country
13.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Zimmer Biomet Holdings
14.1.1 Company Information
14.1.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.1.3 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Smith & Nephew plc
14.2.1 Company Information
14.2.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.2.3 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Matricel GmbH
14.3.1 Company Information
14.3.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.3.3 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 JRI Orthopaedics Ltd.
14.4.1 Company Information
14.4.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.4.3 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Geistlich Pharma AG
14.5.1 Company Information
14.5.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.5.3 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 CartiHeal
14.6.1 Company Information
14.6.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.6.3 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 BioTissue AG
14.7.1 Company Information
14.7.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.7.3 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 B. Braun Melsungen AG
14.8.1 Company Information
14.8.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.8.3 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Arthro-Kinetics
14.9.1 Company Information
14.9.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.9.3 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Anika Therapeutics, Inc.
14.10.1 Company Information
14.10.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Introduction
14.10.3 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Company (2019-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Area
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sals Value Market Share by Type (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Type (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Type (2016-2021)
Table Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Type (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Application (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Application (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Application (2016-2021)
Table Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value Market Share by Application (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Region (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Region (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Country (2016-2021)
Table North America Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Country (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Country (2016-2021)
Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Country (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Country (2016-2021)
Table Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Country (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share by Country (2016-2021)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value (Million USD) Forecast by Type (2022-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share Forecast by Type (2022-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value (Million USD) Forecast by Application (2022-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share Forecast by Application (2022-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value (Million USD) Forecast by Region (2022-2027)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Value Market Share Forecast by Region (2022-2027)
Table Zimmer Biomet Holdings Company Information
Table Zimmer Biomet Holdings Product Introduction
Table Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table Smith & Nephew plc Company Information
Table Smith & Nephew plc Product Introduction
Table Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table Matricel GmbH Company Information
Table Matricel GmbH Product Introduction
Table Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table JRI Orthopaedics Ltd. Company Information
Table JRI Orthopaedics Ltd. Product Introduction
Table JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table Geistlich Pharma AG Company Information
Table Geistlich Pharma AG Product Introduction
Table Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table CartiHeal Company Information
Table CartiHeal Product Introduction
Table CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table BioTissue AG Company Information
Table BioTissue AG Product Introduction
Table BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table B. Braun Melsungen AG Company Information
Table B. Braun Melsungen AG Product Introduction
Table B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table Arthro-Kinetics Company Information
Table Arthro-Kinetics Product Introduction
Table Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)
Table Anika Therapeutics, Inc. Company Information
Table Anika Therapeutics, Inc. Product Introduction
Table Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Sales Value, Gross Margin and Global Share (2019-2021)

Select User License

$2980 Single Licence
$4470 Enterprise Licence
$5960 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries